HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17

Benzinga Newsdesk www.benzinga.com Positive 74.2%

Neg 0% Neu 0% Pos 74.2%

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $15 to $17.